Martinelli, Enrica
 Distribuzione geografica
Continente #
EU - Europa 896
NA - Nord America 715
AS - Asia 158
AF - Africa 12
SA - Sud America 4
Continente sconosciuto - Info sul continente non disponibili 2
OC - Oceania 2
Totale 1.789
Nazione #
US - Stati Uniti d'America 714
DE - Germania 496
SE - Svezia 127
CN - Cina 92
UA - Ucraina 65
IT - Italia 49
FR - Francia 42
GB - Regno Unito 41
IE - Irlanda 29
SG - Singapore 25
IN - India 21
FI - Finlandia 17
RU - Federazione Russa 16
TR - Turchia 15
CI - Costa d'Avorio 12
BE - Belgio 6
BR - Brasile 4
HK - Hong Kong 2
NL - Olanda 2
A1 - Anonimo 1
AM - Armenia 1
AU - Australia 1
CA - Canada 1
CH - Svizzera 1
CZ - Repubblica Ceca 1
EU - Europa 1
HU - Ungheria 1
IS - Islanda 1
JP - Giappone 1
KZ - Kazakistan 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
RO - Romania 1
Totale 1.789
Città #
Chandler 202
Jacksonville 69
Nürnberg 39
San Mateo 39
Ashburn 35
Dublin 29
Ann Arbor 27
Dearborn 26
New York 25
Marseille 21
Nanjing 19
Singapore 17
Wilmington 17
Izmir 15
Boston 14
Lawrence 14
Cattolica 13
Nanchang 13
Abidjan 12
Beijing 10
Lancaster 9
Seattle 8
Boardman 7
Milan 7
Princeton 7
Brussels 6
Changsha 6
Houston 6
Leawood 6
Norwalk 6
Fairfield 5
Kunming 5
Los Angeles 5
Redwood City 5
Tianjin 5
Woodbridge 5
Fremont 4
Hebei 4
Moscow 4
Mountain View 4
Munich 4
Augusta 3
Hefei 3
Jiaxing 3
London 3
Millbury 3
Redmond 3
San Jose 3
Simi Valley 3
São Paulo 3
Andover 2
Bremen 2
Changchun 2
Edinburgh 2
Hong Kong 2
Kemerovo 2
Monmouth Junction 2
Mumbai 2
Perugia 2
Rome 2
University Park 2
Zhengzhou 2
Almaty 1
Amsterdam 1
Auckland 1
Bari 1
Bern 1
Budapest 1
Cambridge 1
Costa Mesa 1
Groningen 1
Guangzhou 1
Hangzhou 1
Helsinki 1
Jinan 1
Lanzhou 1
Lappeenranta 1
Manta 1
Novokuznetsk 1
Orange 1
Palermo 1
Pescara 1
Pune 1
Quzhou 1
San Diego 1
Segrate 1
Shanghai 1
Shaoxing 1
Shenyang 1
Southend 1
Stockholm 1
Tappahannock 1
Toronto 1
Trieste 1
Vertemate con Minoprio 1
Wuhan 1
Yerevan 1
Totale 860
Nome #
Prognostic role of topoisomerase-IIalpha in advanced ovarian cancer patients 243
FOXP3⁺ T regulatory cell modifications in inflammatory bowel disease patients treated with anti-TNFα agents 149
Adrenomedullin in Ovarian Cancer: Foe In Vitro and Friend In Vivo? 143
Gli family transcription factors are drivers of patupilone resistance in ovarian cancer 117
Adoptive immunotherapy with cytokine-induced killer cells generated with a new good manufacturing practice-grade protocol 102
Prognostic role of the recepteur d'origine nantais (RON) expression in ovarian cancer patients 99
Gender influences the class III and V β-tubulin ability to predict poor outcome in colorectal cancer 92
Dual Inhibitor AEE788 Reduces Tumor Growth in Preclinical Models of Medulloblastoma 87
Serous ovarian carcinoma recurring as a heterologous carcinosarcoma 82
Cetuximab continuation after first progression in metastatic colorectal cancer (CAPRI-GOIM): A randomized phase II trial of FOLFOX plus cetuximab versus FOLFOX 79
Identification of high-grade serous ovarian cancer miRNA species associated with survival and drug response in patients receiving neoadjuvant chemotherapy: a retrospective longitudinal analysis using matched tumor biopsie 75
Ovarian low and high grade serous carcinomas: hidden divergent features in the tumor microenvironment 64
Polarisation of Tumor-Associated Macrophages toward M2 Phenotype Correlates with Poor Response to Chemoradiation and Reduced Survival in Patients with Locally Advanced Cervical Cancer. 63
Uncovering the role of nuclear Lysyl oxidase (LOX) in advanced high grade serous ovarian cancer 59
Multiple direct and indirect mechanisms drive estrogen-induced tumor growth in high grade serous ovarian cancers 59
Survivin protein as predictor of pathologic response in patients with locally advanced cervical cancer treated with chemoradiation followed by radical surgery 58
Ambiente e ritualità nelle necropoli di Padova fra età del Ferro ed età romana: i resti macroscopici vegetali 55
Hormone receptor expression profile of low-grade serous ovarian cancers 53
Preoperative Anti-Class III β-Tubulin Antibodies As Relevant Clinical Biomarkers in Ovarian Cancer 51
Identification of high-grade serous ovarian cancer miRNA species associated with survival and drug response in patients receiving neoadjuvant chemotherapy: a retrospective longitudinal analysis using matched tumor biopsies 50
HuR regulates beta-tubulin isotype expression in ovarian cancer 40
Totale 1.820
Categoria #
all - tutte 6.036
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 6.036


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020252 53 12 30 5 10 32 31 11 13 9 26 20
2020/2021157 8 16 3 13 25 7 14 4 20 6 29 12
2021/2022199 15 11 7 16 15 3 3 34 15 13 24 43
2022/2023479 52 74 40 86 17 60 34 41 61 2 7 5
2023/2024155 14 47 1 1 4 30 5 9 0 6 17 21
Totale 1.820